Jacques Chanliau
Overview
Explore the profile of Jacques Chanliau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rossignol P, Lamiral Z, Frimat L, Girerd N, Duarte K, Ferreira J, et al.
Nephrol Dial Transplant
. 2017 May;
32(12):2112-2118.
PMID: 28460113
Background: Observational studies have reported increased mortality rates in hyperkalaemic or hypokalaemic chronic haemodialysis patients. This study assessed the prevalence and recurrence of hyperkalaemia (HK) along with the concomitant prescription...
2.
Thilly N, Chanliau J, Frimat L, Combe C, Merville P, Chauveau P, et al.
BMC Nephrol
. 2017 Apr;
18(1):126.
PMID: 28381266
Background: Home telemonitoring has developed considerably over recent years in chronic diseases in order to improve communication between healthcare professionals and patients and to promote early detection of deteriorating health...
3.
Chanliau J, Charasse C, Rose C, Bene B
Int J Artif Organs
. 2014 Dec;
37(11):809-15.
PMID: 25450325
The monitoring of ionic dialysance in hemodialysis allows early detection of arterio-venous fistula stenosis. One limitation to the practical use of ionic dialysance is that the analysis is very time...
4.
Donck J, Gonzalez-Tabares L, Chanliau J, Martin H, Stamatelou K, Manamley N, et al.
Adv Ther
. 2014 Nov;
31(11):1155-68.
PMID: 25367412
Introduction: There is scant real-world information on switching treatment for anemia associated with chronic kidney disease (CKD) from methoxy polyethylene glycol-epoetin beta (PEG-Epo) to darbepoetin alfa (DA). TRANSFORM was a...
5.
Chanliau J, Kessler M
Nephrol Ther
. 2010 Nov;
7(1):32-7.
PMID: 21112269
Peritoneal dialysis (PD) is as least as good as hemodialysis (HD) for the treatment of end stage kidney disease, considering morbidity and mortality, and better for quality of life. The...
6.
Bouchet J, Brunet P, Canaud B, Chanliau J, Combe C, Deray G, et al.
Nephrol Ther
. 2008 Dec;
5(1):61-6.
PMID: 19084489
The European patents for epoetin alpha recently expired. Biosimilars (i.e. "a medicine which is similar to a biological medicine that has already been authorized" [EMEA 2007]) of epoetins have thus...
7.
Loos-Ayav C, Frimat L, Kessler M, Chanliau J, Durand P, Briancon S
Qual Life Res
. 2007 Nov;
17(1):1-9.
PMID: 18044008
Objective: In the Lorraine area (France), dialysis centers propose an educational program to improve patient's ability to perform dialysis by themselves. The objective was to assess changes in health-related quality...
8.
Canaud B, Kessler M, Chanliau J
Nephrol Ther
. 2007 Mar;
2 Suppl 5:S289.
PMID: 17373272
No abstract available.
9.
Gagnon M, Lamothe L, Hebert M, Chanliau J, Fortin J
Telemed J E Health
. 2006 Jun;
12(3):324-31.
PMID: 16796500
The use of telehomecare has the potential to facilitate access to healthcare services for vulnerable populations. However, evidence on the implications of telehomecare on various aspects related to patients, healthcare...